Work-related problems in multiple sclerosis: a literature review on its associates and determinants

References

• Pugliatti M, Rosati G, Carton H, et al. The epidemiology of multiple sclerosis in Europe. Eur J Neurol 2006;13:700–22
   PubMed Web of Science ®Google Scholar
• Gustavsson A, Svensson M, Jacobi F, et al.; CDBE2010Study Group. Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 2011;21:718–79
   PubMed Web of Science ®Google Scholar
• Confavreux C, Compston A. The natural story of MS. In: Compston A, Confavreux C, Lassmann H, et al., eds. McAlpine’s multiple sclerosis, 4th ed. London: Churchill Livingstone Elsevier; 2006:183–269
   Google Scholar
• Compston A, Coles A. Multiple sclerosis. Lancet 2008;372:1502–17
   PubMed Web of Science ®Google Scholar
• Kobelt G, Berg J, Lindgren P, Jönsson B. Costs and quality of life in multiple sclerosis in Europe: method of assessment and analysis. Eur J Health Econ 2006;7:s5–13
   Google Scholar
• Schiavolin S, Leonardi M, Giovannetti AM, et al. Factors related to difficulties with employment in patients with multiple sclerosis: a review of 2002–2011 literature. Int J Rehabil Res 2013;36:105–11
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Clinical Excellence. The guideline manual. London: National Institute for Health and Clinical Excellence; 2009
   Google Scholar
• Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444–52
   PubMed Web of Science ®Google Scholar
• Popay J, Roberts H, Sowden A, et al. Guidance on the conduct of narrative synthesis in systematic reviews. A product from the ESCR methods Programme. Lancaster: ESRC Methods Program; 2006
   Google Scholar
• Cabello M, Mellor-Marsá B, Sabariego C, et al. Psychosocial features of depression: a systematic literature review. J Affect Disord 2012;141:22–33
   PubMed Web of Science ®Google Scholar
• Quintas R, Raggi A, Giovannetti AM, et al. Psychosocial difficulties in people with epilepsy: a systematic review of literature from 2005 until 2010. Epilepsy Behav 2012;25:60–7
   PubMed Web of Science ®Google Scholar
• Raggi A, Giovannetti AM, Quintas R, et al. A systematic review of the psychosocial difficulties relevant to patients with migraine. J Headache Pain 2012;13:595–606
   PubMed Web of Science ®Google Scholar
• Świtaj P, Anczewska M, Chrostek A, et al. Disability and schizophrenia: a systematic review of experienced psychosocial difficulties. BMC Psychiatr 2012;12:193
   PubMed Web of Science ®Google Scholar
• Levola J, Kaskela T, Holopainen A, et al. Psychosocial difficulties in alcohol dependence: a systematic review of activity limitations and participation restrictions. Disabil Rehabil 2014;36:1227–39
   PubMed Web of Science ®Google Scholar
• Krokavcova M, Nagyova I, Van Dijk JP, et al. Self-rated health and employment status in patients with multiple sclerosis. Disabil Rehabil 2010;32:1742–8
   PubMed Web of Science ®Google Scholar
• Busche KD, Fisk JD, Murray TJ, Metz LM. Short term predictors of unemployment in multiple sclerosis patients. Can J Neurol Sci 2003;30:137–42
   PubMed Web of Science ®Google Scholar
• Strober LB, Christodoulou C, Benedict RH, et al. Unemployment in multiple sclerosis: the contribution of personality and disease. Mult Scler 2012;18:647–53
   PubMed Web of Science ®Google Scholar
• Glad SB, Aarseth JH, Nyland H, et al. Benign multiple sclerosis: a need for a consensus. Acta Neurol Scand Suppl 2010;122(suppl 190):44–50
   Google Scholar
• Glad SB, Nyland H, Aarseth JH, et al. How long can you keep working with benign multiple sclerosis? J Neurol Neurosurg Psychiatr 2011;82:78–82
   PubMed Web of Science ®Google Scholar
• O'Connor RJ, Cano SJ, Ramió i Torrentà L, et al. Factors influencing work retention for people with multiple sclerosis: cross-sectional studies using qualitative and quantitative methods. J Neurol 2005;252:892–6
   PubMed Web of Science ®Google Scholar
• Wickström A, Nyström J, Svenningsson A. Improved ability to work after one year of natalizumab treatment in multiple sclerosis: analysis of disease-specific and work-related factors that influence the effect of treatment. Mult Scler 2013;19:622–30
   PubMed Web of Science ®Google Scholar
• Olofsson S, Wickström A, Häger Glenngård A, et al. Effect of treatment with natalizumab on ability to work in people with multiple sclerosis: productivity gain based on direct measurement of work capacity before and after 1 year of treatment. BioDrugs 2011;25:299–306
   PubMed Web of Science ®Google Scholar
• Smith MM, Arnett PA. Factors related to employment status changes in individuals with multiple sclerosis. Mult Scler 2005;11:602–9
   PubMed Web of Science ®Google Scholar
• Ruet A, Deloire M, Hamel D, et al. Cognitive impairment, health-related quality of life and vocational status at early stages of multiple sclerosis: a 7-year longitudinal study. J Neurol 2013;260:776–84
   PubMed Web of Science ®Google Scholar
• Simmons RD, Tribe KL, McDonald EA. Living with multiple sclerosis: longitudinal changes in employment and the importance of symptom management. J Neurol 2010;257:926–36
   PubMed Web of Science ®Google Scholar
• Julian LJ, Vella L, Vollmer T, et al. Employment in multiple sclerosis. Exiting and re-entering the work force. J Neurol 2008;255:1354–60
   PubMed Web of Science ®Google Scholar
• Flensner G, Landtblom AM, Söderhamn O, Ek AC. Work capacity and health-related quality of life among individuals with multiple sclerosis reduced by fatigue: a cross-sectional study. BMC Public Health 2013;13:224
   PubMed Web of Science ®Google Scholar
• Bøe Lunde HM, Telstad W, Grytten N, et al. Employment among patients with multiple sclerosis-a population study. PLoS One 2014;9:e103317
   PubMed Web of Science ®Google Scholar
• Patten SB, Williams JV, Lavorato DH, et al. Depression as a predictor of occupational transition in a multiple sclerosis cohort. Funct Neurol 2013;28:275–80
   PubMedGoogle Scholar
• Krokavcova M, Nagyova I, Rosenberger J, et al. Employment status and perceived health status in younger and older people with multiple sclerosis. Int J Rehabil Res 2012;35:40–7
   PubMed Web of Science ®Google Scholar
• Frndak SE, Kordovski VM, Cookfair D, et al. Disclosure of disease status among employed multiple sclerosis patients: association with negative work events and accommodations. Mult Scler 2015;21:225–34
   PubMed Web of Science ®Google Scholar
• Casado V, Martínez-Yélamos S, Martínez-Yélamos A, et al. Direct and indirect costs of Multiple Sclerosis in Baix Llobregat (Catalonia, Spain), according to disability. BMC Health Serv Res 2006;6:143
   PubMed Web of Science ®Google Scholar
• Honarmand K, Akbar N, Kou N, Feinstein A. Predicting employment status in multiple sclerosis patients: the utility of the MS functional composite. J Neurol 2011;258:244–9
   PubMed Web of Science ®Google Scholar
• Doward LC, Meads DM, Fisk J, et al. International development of the Unidimensional Fatigue Impact Scale (U-FIS). Value Health 2010;13:463–8
   PubMed Web of Science ®Google Scholar
• Sayao AL, Bueno AM, Devonshire V, Tremlett H; UBC MS Clinic Neurologists. The psychosocial and cognitive impact of longstanding 'benign' multiple sclerosis. Mult Scler 2011;17:1375–83
   PubMed Web of Science ®Google Scholar
• Benedict RH, Wahlig E, Bakshi R, et al. Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change. J Neurol Sci 2005;231:29–34
   PubMed Web of Science ®Google Scholar
• Glanz BI, Dégano IR, Rintell DJ, et al. Work productivity in relapsing multiple sclerosis: associations with disability, depression, fatigue, anxiety, cognition, and health-related quality of life. Value Health 2012;15:1029–35
   PubMed Web of Science ®Google Scholar
• Jacobs LD, Wende KE, Brownscheidle CM, et al. A profile of multiple sclerosis: the New York State Multiple Sclerosis Consortium. Mult Scler 1999;5:369–76
   PubMed Web of Science ®Google Scholar
• Chwastiak LA, Gibbons LE, Ehde DM, et al. Fatigue and psychiatric illness in a large community sample of persons with multiple sclerosis. J Psychosom Res 2005;59:291–8
   PubMed Web of Science ®Google Scholar
• Messmer Uccelli M, Specchia C, Battaglia MA, Miller DM. Factors that influence the employment status of people with multiple sclerosis: a multi-national study. J Neurol 2009;256:1989–96
   PubMed Web of Science ®Google Scholar
• Van der Hiele K, Middelkoop HA, Ruimschotel R, et al. A pilot study on factors involved with work participation in the early stages of multiple sclerosis. PLoS One 2014;9:e105673
   PubMed Web of Science ®Google Scholar
• Honan CA, Brown RF, Hine DW, et al. The multiple sclerosis work difficulties questionnaire. Mult Scler 2012;18:871–80
   PubMed Web of Science ®Google Scholar
• Flensner G, Ek AC, Landtblom AM, Söderhamn O. Fatigue in relation to perceived health: people with multiple sclerosis compared with people in the general population. Scand J Caring Sci 2008;22:391–400
   PubMed Web of Science ®Google Scholar
• Wickström A, Dahle C, Vrethem M, Svenningsson A. Reduced sick leave in multiple sclerosis after one year of natalizumab treatment: a prospective ad hoc analysis of the TYNERGY trial. Mult Scler 2014;20:1095–101
   Web of Science ®Google Scholar
• Ehde DM, Osborne TL, Hanley MA, et al. The scope and nature of pain in persons with multiple sclerosis. Mult Scler 2006;12:629–38
   PubMed Web of Science ®Google Scholar
• Morrow SA, Drake A, Zivadinov R, et al. Predicting loss of employment over three years in multiple sclerosis: clinically meaningful cognitive decline. Clin Neuropsychol 2010;24:1131–45
   PubMed Web of Science ®Google Scholar
• Einarsson U, Gottberg K, von Koch L, et al. Cognitive and motor function in people with multiple sclerosis in Stockholm County. Mult Scler 2006;12:340–53
   PubMed Web of Science ®Google Scholar
• Jongen PJ, Wesnes K, van Geel B, et al.; COGNISEC Study Group. Relationship between working hours and power of attention, memory, fatigue, depression and self-efficacy one year after diagnosis of clinically isolated syndrome and relapsing remitting multiple sclerosis. PLoS One 2014;9:e96444
   PubMed Web of Science ®Google Scholar
• Williams AE, Vietri JT, Isherwood G, Flor A. Symptoms and association with health outcomes in relapsing-remitting multiple sclerosis: results of a US patient survey. Mult Scler Int 2014;2014:203183
   PubMedGoogle Scholar
• Tan-Kristanto S, Kiropoulos LA. Resilience, self-efficacy, coping styles and depressive and anxiety symptoms in those newly diagnosed with multiple sclerosis. Psychol Health Med 2015;20:635--45
   PubMed Web of Science ®Google Scholar
• Salter AR, Cutter GR, Tyry T, et al. Impact of loss of mobility on instrumental activities of daily living and socioeconomic status in patients with MS. Curr Med Res Opin 2010;26:493–500
   PubMed Web of Science ®Google Scholar
• Raggi A, Giovannetti AM, Schiavolin S, et al. Development and validation of the multiple sclerosis questionnaire for the evaluation of job difficulties (MSQ-Job). Acta Neurol Scand 2015. [Epub ahead of print]. DOI: 10.1111/ane.12387
   Web of Science ®Google Scholar
• Ford HL, Gerry E, Johnson MH, Tennant A. Health status and quality of life of people with multiple sclerosis. Disabil Rehabil 2001;23:516–21
   PubMed Web of Science ®Google Scholar
• Forbes A, While A, Mathes L, Griffiths P. Health problems and health-related quality of life in people with multiple sclerosis. Clin Rehabil 2006;20:67–78
   PubMed Web of Science ®Google Scholar
• Bombardier CH, Blake KD, Ehde DM, et al. Alcohol and drug abuse among persons with multiple sclerosis. Mult Scler 2004;10:35–40
   PubMed Web of Science ®Google Scholar
• Rinker JR II, Salter AR, Walker H, et al. Prevalence and characteristics of tremor in the NARCOMS multiple sclerosis registry: a cross-sectional survey. BMJ Open 2015;5:e006714
   Web of Science ®Google Scholar
• Leray E, Coustans M, Le Page E, et al. ‘Clinically definite benign multiple sclerosis', an unwarranted conceptual hodgepodge: evidence from a 30-year observational study. Mult Scler 2013;19:458–65
   PubMed Web of Science ®Google Scholar
• Kappos L, Radue EW, O'Connor P, et al.; FREEDOMS Study Group. A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N Engl J Med 2010;362:387–401
   PubMed Web of Science ®Google Scholar
• McCormack PL. Natalizumab: a review of its use in the management of relapsing-remitting multiple sclerosis. Drugs 2013;73:1463–81
   PubMed Web of Science ®Google Scholar
• Scalfari A, Neuhaus A, Daumer M, et al. Age and disability accumulation in multiple sclerosis. Neurology 2011;77:1246–52
   PubMed Web of Science ®Google Scholar
• Iaffaldano P, Viterbo RG, Paolicelli D, et al. Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: a prospective, open-label, two years observational study. PLoS One 2012;7:e35843
   PubMed Web of Science ®Google Scholar
• Svenningsson A, Falk E, Celius EG, et al.; Tynergy Trial Investigators. Natalizumab treatment reduces fatigue in multiple sclerosis. Results from the TYNERGY trial; a study in the real life setting. PLoS One 2013;8:e58643
   PubMed Web of Science ®Google Scholar
• Drulovic J, Bursac LO, Milojkovic D, et al. MSQoL-54 predicts change in fatigue after inpatient rehabilitation for people with multiple sclerosis. Disabil Rehabil 2013;35:362–6
   PubMed Web of Science ®Google Scholar
• Hebert JR, Corboy JR, Manago MM, Schenkman M. Effects of vestibular rehabilitation on multiple sclerosis-related fatigue and upright postural control: a randomized controlled trial. Phys Ther 2011;91:1166–83
   PubMed Web of Science ®Google Scholar
• Judica E, Martinelli Boneschi F, Ungaro D, et al. Impact of fatigue on the efficacy of rehabilitation in multiple sclerosis. J Neurol 2011;258:835–9
   PubMed Web of Science ®Google Scholar
• Asano M, Berg E, Johnson K, et al. A scoping review of rehabilitation interventions that reduce fatigue among adults with multiple sclerosis. Disabil Rehabil 2015;37:729–38
   PubMed Web of Science ®Google Scholar
• Baert I, Freeman J, Smedal T, et al. Responsiveness and clinically meaningful improvement, according to disability level, of five walking measures after rehabilitation in multiple sclerosis: a European multicenter study. Neurorehabil Neural Repair 2014;28:621–31
   PubMed Web of Science ®Google Scholar
• Vaney C, Gattlen B, Lugon-Moulin V, et al. Robotic-assisted step training (lokomat) not superior to equal intensity of over-ground rehabilitation in patients with multiple sclerosis. Neurorehabil Neural Repair 2012;26:212–21
   PubMed Web of Science ®Google Scholar
• Nick ST, Roberts C, Billiodeaux S, et al. Multiple sclerosis and pain. Neurol Res 2012;34:829–41
   PubMed Web of Science ®Google Scholar
• Shahrbanian S, Auais M, Duquette P, et al. Does pain in individuals with multiple sclerosis affect employment? A systematic review and meta-analysis. Pain Res Manag 2013;18:e94–100
   PubMed Web of Science ®Google Scholar
• Feinstein A. Multiple sclerosis and depression. Mult Scler 2011;17:1276–81
   PubMed Web of Science ®Google Scholar
• Goretti B, Viterbo RG, Portaccio E, et al. Anxiety state affects information processing speed in patients with multiple sclerosis. Neurol Sci 2014;35:559–63
   PubMed Web of Science ®Google Scholar
• Jones KH, Ford DV, Jones PA, et al. A large-scale study of anxiety and depression in people with multiple sclerosis: a survey via the web portal of the UK MS Register. PLoS One 2012;7:e41910
   PubMed Web of Science ®Google Scholar
• Wood B, van der Mei IA, Ponsonby AL, et al. Prevalence and concurrence of anxiety, depression and fatigue over time in multiple sclerosis. Mult Scler 2013;19:217–24
   PubMed Web of Science ®Google Scholar
• Jongen PJ, Ter Horst AT, Brands AM. Cognitive impairment in multiple sclerosis. Minerva Med 2012;103:73–96
   PubMed Web of Science ®Google Scholar
• Chiaravalloti ND, DeLuca J. Cognitive impairment in multiple sclerosis. Lancet Neurol 2008;7:1139–51
   PubMed Web of Science ®Google Scholar
• Rosti-Otajärvi EM, Hämäläinen PI. Neuropsychological rehabilitation for multiple sclerosis. Cochrane Database Syst Rev 2014;2:CD009131
   PubMed Web of Science ®Google Scholar
• O’Brien AR, Chiaravalloti N, Goverover Y, Deluca J. Evidenced-based cognitive rehabilitation for persons with multiple sclerosis: a review of the literature. Arch Phys Med Rehabil 2008;89:761–9
   PubMed Web of Science ®Google Scholar
• Mattioli F, Stampatori C, Bellomi F, et al. Neuropsychological rehabilitation in adult multiple sclerosis. Neurol Sci 2010;31:S271–4
   PubMed Web of Science ®Google Scholar
• Ben Ari Shevil E, Johansson S, Ytterberg C, et al. How are cognitive impairment, fatigue and signs of depression related to participation in daily life among persons with multiple sclerosis? Disabil Rehabil 2014;36:2012–18
   PubMed Web of Science ®Google Scholar
• Neath J, Roessler RT, McMahon BT, Rumrill PD. Patterns in perceived employment discrimination for adults with multiple sclerosis. Work 2007;29:255–74
   PubMedGoogle Scholar
• Rumrill PD Jr, Roessler RT, McMahon BT, et al. Gender as a differential indicator of the employment discrimination experiences of Americans with multiple sclerosis. Work 2007;29:303–11
   PubMedGoogle Scholar
• Khan F, Ng L, Turner-Stokes L. Effectiveness of vocational rehabilitation intervention on the return to work and employment of persons with multiple sclerosis. Cochrane Database Syst Rev 2009;21:CD007256
   Google Scholar
• Chiu CY, Chan F, Bishop M, et al. State vocational rehabilitation services and employment in multiple sclerosis. Mult Scler 2013;19:1655–64
   PubMed Web of Science ®Google Scholar
• Sweetland J, Riazi A, Cano SJ, Playford ED. Vocational rehabilitation services for people with multiple sclerosis: what patients want from clinicians and employers. Mult Scler 2007;13:1183–9
   PubMed Web of Science ®Google Scholar
• Honan CA, Brown RF, Hine DW. The multiple sclerosis work difficulties questionnaire (MSWDQ): development of a shortened scale. Disabil Rehabil 2014;36:635–41
   PubMed Web of Science ®Google Scholar
• Mcfadden E, Horton MC, Ford HL, et al. Screening for the risk of job loss in multiple sclerosis (MS): development of an MS-specific work instability scale (MS-WIS). Mult Scler 2012;18:862–70
   PubMed Web of Science ®Google Scholar